Extraction method of gypenoside

Through the combination of ultrasonic assisted extraction and enzymatic treatment, combined with the purification technology of nanofiltration membrane and macroporous adsorption resin, the problems of low extraction efficiency and purity in gynostemma saponin extraction are solved, and efficient and environmentally friendly extraction methods are achieved, and the utilization of medicinal materials is improved. rate and product purity.

CN118903239APending Publication Date: 2024-11-08HUNAN CHUNGUANG JIUHUI MODERN CHINESE MEDICINE CO LTD
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202410899223.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-05
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The prior art has low extraction efficiency in the extraction of gynostemma saponin, low product purity, and cannot effectively utilize unextracted saponin in the drug residue, which has problems of waste of resources and complexity of the process.

Method used

Ultrasonic assisted extraction combined with enzymatic lysis treatment and nanofiltration membrane and macroporous adsorption resin purification were used to improve the extraction rate and purity, and the unextracted saponin in the drug residue was reused through enzymatic lysis treatment.

Benefits of technology

It significantly improves the extraction rate and purity of gynostemta saponin, realizes the efficient utilization of medicinal materials resources, simplifies the process flow, and improves the medicinal value and market competitiveness of the product.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to the technical field of extraction methods of active ingredients of medicinal materials, in particular to an extraction method of gynostemma pentaphyllum saponin, which is characterized by comprising the following steps: S1, crushing a raw material gynostemma pentaphyllum into powder, soaking the powder in a solvent, and performing ultrasonic-assisted extraction to obtain a gynostemma pentaphyllum mixed solution; s2, carrying out solid-liquid separation on the gynostemma pentaphyllum mixed solution to obtain a gynostemma pentaphyllum saponin extracting solution and residual medicine residues containing unextracted saponin; s3, adding enzymes into the residual medicine residues containing the unextracted saponins to carry out enzymolysis treatment, and repeating the operation of the step S1; and S4, purifying the gypenoside extracting solution through a nanofiltration membrane, and then purifying through macroporous adsorption resin to obtain the gypenoside. The extraction method provided by the invention not only can improve the extraction rate and purity of the gypenoside, but also recycles the medicine residues, and improves the utilization rate of the medicine residues.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of methods for extracting effective components of medicinal materials, and in particular to a method for extracting gypenosin. Background Art

[0002] Gynostemma pentaphyllum (GP) is a perennial herbaceous vine of the Cucurbitaceae family, also known as five-leaf ginseng and seven-leaf gall. It is a traditional natural medicinal plant used for both medicine and food. Studies have shown that gypenosides are the main active ingredients of Gynostemma pentaphyllum, which have the effects of lowering blood lipids, anti-mutagenicity, anti-aging, enhancing immunity and protecting the liver. It has become a hot target for development at home and abroad. However, due to unreasonable development, excessive picking and habitat destruction, the number of Gynostemma pentaphyllum has rapidly decreased, so that the germplasm resources are threatened. At the same time, due to the confusion of varieties of Gynostemma pentaphyllum medicinal materials, the saponins and their contents from different origins, different medicinal parts and collection times vary greatly; different extraction processes seriously affect the composition and proportion of Gynostemma pentaphyllum saponin extracts.

[0003] Traditional extraction and precipitation methods usually involve the use of organic solvents (such as ethanol) to extract Gynostemma pentaphyllum, followed by stratification and precipitation by standing or adding water, and finally obtaining a saponin extract. This method is simple, but there are problems such as low extraction efficiency, low product purity, and difficulty in solvent recovery, and it is impossible to effectively utilize the unextracted saponins in the drug residues. Ultrasonic-assisted extraction has attracted widespread attention as an emerging technology. This method uses ultrasonic energy to promote the extraction of active ingredients in plant materials by solvents, significantly improving the extraction rate and efficiency. However, the existing ultrasonic-assisted extraction method still has technical difficulties in processing drug residues, such as how to efficiently utilize the saponins remaining in the drug residues, and how to improve the purity and yield of the extract.

[0004] Therefore, it is of great significance to have a method for extracting gypenosides that can improve the extraction rate and the utilization rate of medicinal residues. Summary of the invention

[0005] The present invention aims to solve at least one of the technical problems existing in the prior art. To this end, the present invention provides a method for extracting gypenosin, which can not only improve the extraction rate and purity of gypenosin, but also recycle the medicinal residues and improve the utilization rate of the medicinal residues.

[0006] The first aspect of the present invention provides a method for extracting gypenosides, the steps of the extraction method are as follows:

[0007] S1, crushing the raw material Gynostemma pentaphyllum into powder, soaking it in a solvent, and performing ultrasonic-assisted extraction to obtain a Gynostemma pentaphyllum mixed solution;

[0008] S2, separating the solid-liquid of the mixed solution of Gynostemma pentaphyllum to obtain a Gynostemma pentaphyllum saponin extract and residual medicinal residues containing unextracted saponins;

[0009] S3, adding enzymes to the residual drug residues containing unextracted saponins for enzymatic hydrolysis, and repeating step S1;

[0010] S4, purifying the gypenosin extract by nanofiltration membrane, and then purifying it by macroporous adsorption resin to obtain gypenosin

[0011] According to some embodiments of the present invention, in step S1, the raw material Gynostemma pentaphyllum is crushed and then passed through a 40-60 mesh sieve.

[0012] According to some embodiments of the present invention, in step S1, the solvent includes at least one of water, ethanol, acetone, ethyl acetate, ethanol, dimethylformamide and dimethyl sulfoxide.

[0013] According to some embodiments of the present invention, in step S1, the soaking time is 1 to 2 hours.

[0014] According to some embodiments of the present invention, in step S1, the solid-liquid ratio of the raw material Gynostemma pentaphyllum powder and the solvent is 1:30-60 g / mL.

[0015] Preferably, in step S1, the solid-liquid ratio of the raw material Gynostemma pentaphyllum powder and the solvent is 1:40-50 g / mL.

[0016] According to some embodiments of the present invention, in step S1, the frequency of the ultrasonic wave-assisted extraction is 20 kHz to 100 kHz.

[0017] Preferably, in step S1, the frequency of the ultrasonic-assisted extraction is 40 kHz to 80 kHz.

[0018] According to some embodiments of the present invention, in step S1, the power of the ultrasonic-assisted extraction is 20W to 200W.

[0019] Preferably, in step S1, the power of the ultrasonic-assisted extraction is 40W to 100W.

[0020] According to some embodiments of the present invention, in step S1, the ultrasonic-assisted extraction takes 30 min to 60 min.

[0021] According to some embodiments of the present invention, in step S1, the temperature of the ultrasonic-assisted extraction is 20-40°C.

[0022] According to some embodiments of the present invention, in step S2, the solid-liquid separation includes standing for stratification for 1 to 2 hours.

[0023] According to some embodiments of the present invention, in step S3, the enzymes include at least one of glucosidase, lipase, cellulase, hemicellulase, pectinase and protease.

[0024] According to some embodiments of the present invention, in step S3, the enzymes are added by adding one enzyme in steps or adding two or three complex enzymes at the same time. For example, it can be:

[0025] When two enzymes are added simultaneously, the enzymes may be glucosidase and cellulase; the mass ratio of the glucosidase to the cellulase is 1:(1-1.5).

[0026] When three enzymes are added simultaneously, the enzymes may be pectinase, hemicellulase and cellulase. The mass ratio of pectinase, hemicellulase and cellulase is 1:(1-1.5):(1-1.5).

[0027] According to some embodiments of the present invention, in step S3, the enzyme is added in an amount of 1 to 6 g per kilogram of residual medicinal residue.

[0028] According to some embodiments of the present invention, in step S3, the enzyme activity of the enzyme is 10,000 to 50,000 U / g.

[0029] According to some embodiments of the present invention, in step S3, the temperature of the enzymatic hydrolysis treatment is 30-50°C.

[0030] According to some embodiments of the present invention, in step S3, the enzymatic treatment time is 2 to 4 hours.

[0031] According to some embodiments of the present invention, in step S3, the pH value of the enzymatic hydrolysis treatment is 4.5-6.5.

[0032] According to some embodiments of the present invention, in step S4, the pore size of the nanofiltration membrane is 0.01-0.1 μm.

[0033] According to some embodiments of the present invention, in step S4, the macroporous adsorption resin is macroporous adsorption resin HPD-100.

[0034] According to some embodiments of the present invention, in step S4, the purification process comprises the following steps:

[0035] a. Apply the nanofiltered Gynostemma pentaphyllum saponin extract to the column;

[0036] b. Wash with deionized water to remove impurities;

[0037] c. Elute with ethanol solution to collect Gynostemma pentaphyllum saponins.

[0038] The extraction method according to the embodiment of the present invention has at least the following beneficial effects:

[0039] The extraction method of the present invention significantly improves the extraction rate by combining ultrasonic assisted extraction and enzymatic hydrolysis, especially for difficult-to-extract saponin compounds, showing unexpected high efficiency. Compared with the traditional solvent extraction method, ultrasonic assisted extraction can destroy the cell wall and accelerate the release of effective ingredients, thereby improving the extraction rate of gypenosin; by enzymatic hydrolysis of incompletely extracted drug residues, the residual gypenosin can be further released, the total extraction rate can be improved, and medicinal resources can be effectively utilized. Through the combined use of nanofiltration membrane and macroporous adsorption resin, impurities in the extract can be effectively removed, the purity of gypenosin can be improved, and the final product has higher medicinal value and market competitiveness.

[0040] Simple solvents such as water or ethanol are usually used for extraction, but it is difficult to balance the extraction rate and purity. Increasing the amount of solvent or extending the extraction time can increase the extraction rate, but the impurity content in the extract also increases accordingly, and the purity is difficult to guarantee. Although conventional ultrasonic-assisted extraction can improve the extraction efficiency, it does not consider the reuse of the drug residue, resulting in a large waste of resources, and requires complex purification steps after extraction, which increases the complexity and cost of the process. Even if attempts are made to reuse the drug residue, the extraction efficiency of unextracted saponins is still low through conventional crushing and solvent extraction, and the total extraction rate cannot be significantly improved.

[0041] The present invention combines multiple technical means such as ultrasonic assisted extraction, enzymatic hydrolysis and re-extraction of medicinal residues, nanofiltration membrane purification and macroporous adsorption resin purification to form a set of efficient, environmentally friendly and economical gypenosin extraction methods. Compared with the existing technology, this scheme not only significantly improves the extraction rate and purity, realizes the efficient use of medicinal materials, but also simplifies the process flow, and has significant innovation and practicality.

[0042] Other features and advantages of the present invention will be set forth in the description which follows, and in part will be apparent from the description, or may be learned by practice of the present invention. DETAILED DESCRIPTION

[0043] The following will be combined with the embodiments to clearly and completely describe the concept of the present invention and the technical effects produced, so as to fully understand the purpose, characteristics and effects of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, other embodiments obtained by those skilled in the art without creative work are all within the scope of protection of the present invention.

[0044] The embodiments of the present invention are described in detail below, and the examples of the embodiments are shown in Figure 1. The same or similar reference numerals throughout represent the same or similar elements or elements with the same or similar functions. The following embodiments are exemplary and are only used to explain the present invention, and cannot be understood as limiting the present invention.

[0045] In the description of the present invention, unless otherwise clearly defined, terms such as setting, installing, connecting, etc. should be understood in a broad sense, and technicians in the relevant technical field can reasonably determine the specific meanings of the above terms in the present invention based on the specific content of the technical solution.

[0046] In the description of the present invention, the description with reference to the terms "one embodiment", "some embodiments", "illustrative embodiments", "examples", "specific examples", or "some examples" means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representation of the above terms does not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner.

[0047] Example 1

[0048] This embodiment provides a method for extracting gypenosides, and the steps of the extraction method are as follows:

[0049] 1) 1 kg of raw material Gynostemma pentaphyllum powder was passed through a 40-mesh sieve and mixed with 70% ethanol solution (solid-liquid ratio 1:50 g / mL). The ultrasonic-assisted extraction conditions were: frequency 50 kHz, power 100 W, time 45 minutes, temperature 30°C.

[0050] 2) After the mixed solution of Gynostemma pentaphyllum was allowed to stand for stratification, the solid and liquid were separated for 1.5 hours to obtain the Gynostemma pentaphyllum saponin extract and residual drug residues.

[0051] 3) Use compound enzyme to treat the residual drug residue: add glucosidase and cellulase (mass ratio 1:1.2) at the same time, add 4g compound enzyme per kilogram of residual drug residue. The enzymatic treatment conditions are: temperature 40°C, time 3 hours, pH value 5.5.

[0052] 4) The gypenosin extract was purified by a 0.05 μm nanofiltration membrane and then purified by a macroporous adsorption resin HPD-100. Purification process: a. The nanofiltered extract was loaded onto a column. b. Impurities were eluted with deionized water. c. Gynostemma pentaphyllum saponins were collected by elution with an ethanol solution to obtain 105 g of gypenosin, with an extraction rate of 10.5% and a purity of 98%.

[0053] Example 2

[0054] This embodiment provides a method for extracting gypenosides, and the steps of the extraction method are as follows:

[0055] 1) 1 kg of raw material Gynostemma pentaphyllum powder was passed through a 40-mesh sieve and mixed with 70% ethanol solution (solid-liquid ratio 1:50 g / mL). The ultrasonic-assisted extraction conditions were: frequency 50 kHz, power 100 W, time 45 minutes, temperature 30°C.

[0056] 2) After the mixed solution of Gynostemma pentaphyllum was allowed to stand for stratification, the solid and liquid were separated for 1.5 hours to obtain the Gynostemma pentaphyllum saponin extract and residual drug residues.

[0057] 3) Treat the residual drug residue with compound enzymes, add pectinase, hemicellulase and cellulase (mass ratio 1:1.2:1.2) at the same time, add 6g compound enzymes per kilogram of residual drug residues. The enzymatic treatment conditions are: temperature 40°C, time 3 hours, pH 5.5.

[0058] 4) The gypenosin extract was purified by a 0.05 μm nanofiltration membrane and then purified by a macroporous adsorption resin HPD-100. Purification process: a. The nanofiltered extract was loaded onto a column. b. Impurities were eluted with deionized water. c. Gynostemma pentaphyllum saponins were collected by elution with an ethanol solution to obtain 123 g of gypenosin, with an extraction rate of 12.3% and a purity of 99%.

[0059] Example 3

[0060] This embodiment provides a method for extracting gypenosides, and the steps of the extraction method are as follows:

[0061] 1) 1 kg of raw material Gynostemma pentaphyllum powder was passed through a 40-mesh sieve and mixed with 70% ethanol solution (solid-liquid ratio 1:50 g / mL). The ultrasonic-assisted extraction conditions were: frequency 50 kHz, power 100 W, time 45 minutes, temperature 30°C.

[0062] 2) After the mixed solution of Gynostemma pentaphyllum was allowed to stand for stratification, the solid and liquid were separated for 1.5 hours to obtain the Gynostemma pentaphyllum saponin extract and residual drug residues.

[0063] 3) The residual drug residues were treated with a composite enzyme, and pectinase and protease (mass ratio 3:1) were added at the same time, and 6 g of composite enzyme was added per kilogram of residual drug residues. The enzymatic treatment conditions were: temperature 40°C, time 3 hours, and pH 5.5.

[0064] 4) The gypenosin extract was purified by a 0.05 μm nanofiltration membrane and then purified by a macroporous adsorption resin HPD-100. Purification process: a. The nanofiltered extract was loaded onto a column. b. Impurities were eluted with deionized water. c. Gynostemma pentaphyllum saponins were collected by elution with an ethanol solution to obtain 95 g of gypenosin, with an extraction rate of 9.5% and a purity of 99%.

[0065] Comparative Example 1

[0066] This comparative example provides a method for extracting gypenosides, which is different from Example 1 in that a single cellulase is used to enzymatically hydrolyze the medicinal residues, and 3 g of cellulase is added per kilogram of residual medicinal residues.

[0067] The final amount of glycyrrhizin obtained is about 40.5 grams, the extraction rate is about 4.05%, and the product purity reaches 97%.

[0068] Comparative Example 2

[0069] This comparative example provides a method for extracting gypenosides, which is different from Example 1 in that microwave-assisted extraction of gypenosides from residual medicinal residues is used, and the treatment conditions are intermittent microwave treatment for 30 seconds and 6 times. The final gypenosides obtained have a gram weight of about 50 grams, an extraction rate of about 5%, and a product purity of 95%.

[0070] In summary, the present invention combines the process of enzymatic hydrolysis treatment and ultrasonic-assisted extraction, which can significantly improve the extraction rate of gypenosides. Compared with the traditional single ultrasonic extraction, the residual drug residues are subjected to enzymatic hydrolysis and then ultrasonic extraction, and the extraction rate can be increased by 20%-50%, or even higher. The enzymatic hydrolysis treatment of the present invention can degrade some impurities and macromolecular substances in the residual drug residues, and then after ultrasonic extraction and subsequent purification steps, the purity of the gypenosides extract finally obtained is also higher. The synergistic effect of the present invention improves the extraction efficiency, and a high extraction rate can be achieved in a relatively short time, thereby shortening the time of the entire extraction process, and the extracted drug residues can be recycled.

[0071] The above is a detailed description of the embodiments of the present invention, but the present invention is not limited to the above embodiments. Various changes can be made within the knowledge of ordinary technicians in the relevant technical field without departing from the purpose of the present invention. In addition, the embodiments of the present invention and the features in the embodiments can be combined with each other without conflict.

Claims

1. A method for extracting gypenosides, It is characterized in that The extraction method comprises the following steps: S1, crushing the raw material Gynostemma pentaphyllum into powder, soaking it in a solvent, and performing ultrasonic-assisted extraction to obtain a Gynostemma pentaphyllum mixed solution; S2, separating the solid-liquid of the mixed solution of Gynostemma pentaphyllum to obtain a Gynostemma pentaphyllum saponin extract and residual medicinal residues containing unextracted saponins; S3, adding enzymes to the residual drug residues containing unextracted saponins for enzymatic hydrolysis, and repeating step S1; S4, purifying the gypenosin extract by a nanofiltration membrane, and then purifying it by a macroporous adsorption resin to obtain gypenosin.

2. The extraction method according to claim 1, It is characterized in that In step S1, the raw material Gynostemma pentaphyllum is crushed and then passed through a 40-60 mesh sieve; preferably, in step S1, the solvent includes at least one of water, ethanol, acetone, ethyl acetate, ethanol, dimethylformamide and dimethyl sulfoxide; preferably, in step S1, the soaking time is 1-2 hours.

3. The extraction method according to claim 1, It is characterized in that In step S1, the solid-liquid ratio of the raw material Gynostemma pentaphyllum powder and the solvent is 1:30-60 g / mL.

4. The extraction method according to claim 1, It is characterized in that In step S1, the frequency of the ultrasonic-assisted extraction is 20kHz to 100kHz; preferably, in step S1, the power of the ultrasonic-assisted extraction is 20W to 200W; preferably, in step S1, the time of the ultrasonic-assisted extraction is 30min to 60min; preferably, in step S1, the temperature of the ultrasonic-assisted extraction is 20 to 40°C.

5. The extraction method according to claim 1, It is characterized in that In step S2, the solid-liquid separation includes standing and stratifying for 1 to 2 hours.

6. The extraction method according to claim 1, It is characterized in that In step S3, the enzymes include at least one of glucosidase, lipase, cellulase, hemicellulase, pectinase and protease; preferably, in step S3, the enzymes are added by adding one in steps or adding two or three complex enzymes at the same time.

7. The extraction method according to claim 1, It is characterized in that In step S3, the enzyme is added in an amount of 1 to 6 g per kilogram of residual medicinal residue; preferably, in step S3, the enzyme activity of the enzyme is 10,000 to 50,000 U / g.

8. The extraction method according to claim 1, It is characterized in that In step S3, the temperature of the enzymatic hydrolysis treatment is 30-50°C; preferably, in step S3, the time of the enzymatic hydrolysis treatment is 2-4 hours; preferably, in step S3, the pH value of the enzymatic hydrolysis treatment is 4.5-6.

5.

9. The extraction method according to claim 1, It is characterized in that In step S4, the pore size of the nanofiltration membrane is 0.01-0.1 μm; preferably, in step S4, the macroporous adsorption resin is macroporous adsorption resin HPD-100.

10. The extraction method according to claim 1, It is characterized in that In step S4, the purification process includes the following steps: a. Apply the nanofiltered Gynostemma pentaphyllum saponin extract to the column; b. Wash with deionized water to remove impurities; c. Elute with ethanol solution to collect Gynostemma pentaphyllum saponins.

Citation Information

Patent Citations

  • Preparation method of high-purity gynostemma pentaphylla total saponin for veterinary drug

    CN103520256A

  • Microwave wall-breaking extraction process of gynostemma pentaphylla extracting solution

    CN105232611A

  • Gynostemma pentaphylla saponin extract and preparation method thereof

    CN112159451A

  • Method for separating multiple natural active ingredients from gynostemma pentaphylla

    CN113813298A